Bromfenac/moxifloxacin/prednisolone ophthalmic Interactions
There are 115 drugs known to interact with bromfenac/moxifloxacin/prednisolone ophthalmic, along with 3 disease interactions. Of the total drug interactions, 1 is major, 113 are moderate, and 1 is minor.
- View all 115 medications that may interact with bromfenac/moxifloxacin/prednisolone ophthalmic
- View bromfenac/moxifloxacin/prednisolone ophthalmic disease interactions (3)
Most frequently checked interactions
View interaction reports for bromfenac / moxifloxacin / prednisolone ophthalmic and the medicines listed below.
- Aspirin Low Strength (aspirin)
- Benadryl (diphenhydramine)
- Colace (docusate)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- Eliquis (apixaban)
- Fish Oil Ultra (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- Lexapro (escitalopram)
- Lidoderm (lidocaine topical)
- Lipitor (atorvastatin)
- Lyrica (pregabalin)
- Metamucil (psyllium)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Mucinex (guaifenesin)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Paxlovid (nirmatrelvir / ritonavir)
- Pepto-Bismol (bismuth subsalicylate)
- Pradaxa (dabigatran)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Protonix (pantoprazole)
- Super B Complex (multivitamin)
- TobraDex (dexamethasone / tobramycin ophthalmic)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
- Voltaren Arthritis Pain Gel (diclofenac topical)
Bromfenac/moxifloxacin/prednisolone ophthalmic disease interactions
There are 3 disease interactions with bromfenac / moxifloxacin / prednisolone ophthalmic which include:
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.